Finazzi G - Search Results

1

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA, Barosi G, Verstovsek S, Birgegard G, Mesa R, Reilly JT, Gisslinger H, Vannucchi AM, Cervantes F, Finazzi G, Hoffman R, Gilliland DG, Bloomfield CD, Vardiman JW. Tefferi A, et al. Among authors: finazzi g. Blood. 2007 Aug 15;110(4):1092-7. doi: 10.1182/blood-2007-04-083501. Epub 2007 May 8. Blood. 2007. PMID: 17488875 Free article.

2

A frameshift mutation leading to type 1 antithrombin deficiency and thrombosis.

Olds RJ, Lane DA, Finazzi G, Barbui T, Thein SL. Olds RJ, et al. Among authors: finazzi g. Blood. 1990 Dec 1;76(11):2182-6. Blood. 1990. PMID: 1979501 Free article.

3

High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura.

Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T. Cortelazzo S, et al. Among authors: finazzi g. Blood. 1991 Jan 1;77(1):31-3. Blood. 1991. PMID: 1984800 Free article.

4

A retrospective study on oral anticoagulant prophylaxis in 103 Italian patients with hereditary thrombophilia and thrombosis. ad hoc Study Group.

Finazzi G, Barbui T. Finazzi G, et al. Ric Clin Lab. 1990 Oct-Dec;20(4):245-52. doi: 10.1007/BF02900709. Ric Clin Lab. 1990. PMID: 2075376

5

[Congenital deficiency of antithrombin III].

Finazzi G, Barbui T. Finazzi G, et al. Haematologica. 1990 Mar-Apr;75 Suppl 2:6-13. Haematologica. 1990. PMID: 2201606 Review. Italian. No abstract available.

6

Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia.

Cortelazzo S, Viero P, Finazzi G, D'Emilio A, Rodeghiero F, Barbui T. Cortelazzo S, et al. Among authors: finazzi g. J Clin Oncol. 1990 Mar;8(3):556-62. doi: 10.1200/JCO.1990.8.3.556. J Clin Oncol. 1990. PMID: 2307991

7

Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.

Galli M, Finazzi G, Bevers EM, Barbui T. Galli M, et al. Among authors: finazzi g. Blood. 1995 Jul 15;86(2):617-23. Blood. 1995. PMID: 7605991 Free article.

8

Clinical trials on antiphospholipid syndrome: what is being done and what is needed?

Barbui T, Finazzi G. Barbui T, et al. Among authors: finazzi g. Lupus. 1994 Aug;3(4):303-7. doi: 10.1177/096120339400300419. Lupus. 1994. PMID: 7804321 Review. No abstract available.

9

Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S.

Finazzi G, Barbui T. Finazzi G, et al. Thromb Haemost. 1994 Jan;71(1):15-8. Thromb Haemost. 1994. PMID: 8165635

10

Feasibility of a randomized clinical trial for the prevention of recurrent thrombosis in the antiphospholipid syndrome: the WAPS project. Provisional Steering Committee of the Warfarin in Antiphospholipid Syndrome (WAPS) Study.

Finazzi G, Barbui T. Finazzi G, et al. Ann Med Interne (Paris). 1996 Sep;147 Suppl 1:38-41. Ann Med Interne (Paris). 1996. PMID: 8952760 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

370 results

Search Page